Found 103 matching trials
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
N/AThe primary objective of the study is to evaluate the adherence to the trea...
Location
Multiple Locations
IFN Beta-1b and Ribavirin for Covid-19
PHASE2As of 1 July 2020, more than 10 million people been confirmed to have infec...
Location
The University of Hong Kong, Queen Mary Hospital
Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study
N/AThe planned study will be a prospective, non-interventional, observational ...
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)
PHASE2The primary objectives of the study are to evaluate the safety of BIIB061 v...
Location
Multiple Locations
BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon
N/AConsidering the significance of an early and consequent Multiple Sclerosis ...
Location
Multiple Locations
Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
N/AThe purpose of this study is to determine whether interferon-beta impairs t...
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change
PHASE4The purpose of this study is to evaluate the change in patient-reported tre...
Location
Novartis Investigative Site
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
PHASE3The purpose of this study is to determine
* whether treatment with Betafer...
Location
Multiple Locations
Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
PHASE2This is a one-year multi-centre, double blind, placebo controlled, randomiz...
Location
Multiple Locations
Pulse ACTH vs. MP for MS
PHASE1We hypothesize that corticotropin or adrenocorticotrophic hormone (ACTH), a...